The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

The global viral vaccines market size was valued at USD 45.20 billion in 2024 and is projected to reach from USD 49 billion ...